Bramble

Synopsis: The benefits of GLP-1 weight-loss drugs (like semaglutide) are frequently overstated due to selective reporting, industry influence, and widespread conflicts of interest in both research and media coverage.

While they can produce short-term weight loss, results vary widely, often plateau within a year, and are difficult to maintain—especially since discontinuation leads to rapid weight regain and loss of health benefits.

Cardiovascular benefits are modest and inconsistently distributed across populations, and adverse effects—ranging from common gastrointestinal issues to serious complications—may be underreported.

already suggested a

sapphibbatical

7 years ago someone posted this-

And 5 years a different user posted this-

thank god nobody's keeping track of the chocolate count, that would probably be Really embarrassing for you. TOO embarrassing for you. right, everyone?

donate

Synopsis: The benefits of GLP-1 weight-loss drugs (like semaglutide) are frequently overstated due to selective reporting, industry influence, and widespread conflicts of interest in both research and media coverage.

While they can produce short-term weight loss, results vary widely, often plateau within a year, and are difficult to maintain—especially since discontinuation leads to rapid weight regain and loss of health benefits.

Cardiovascular benefits are modest and inconsistently distributed across populations, and adverse effects—ranging from common gastrointestinal issues to serious complications—may be underreported.

he so small only need one popcorn 🍿

(ref below cut)